Probiotics and prebiotics for gastrointestinal infections

Current Infectious Disease Reports

Volumn 8, Issue 2, 2006, Pages 103-109

  Novak, Josua ^b   Katz, Jeffry A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTEREMIA; BACTERIAL GROWTH; BIFIDOBACTERIUM; CELL STIMULATION; CLINICAL TRIAL; DIARRHEA; DIVERTICULOSIS; DRUG MECHANISM; ENTEROINVASIVE ESCHERICHIA COLI; FUNGEMIA; GASTROINTESTINAL INFECTION; GASTROINTESTINAL MUCOSA; GROWTH INHIBITION; HEALTH PROMOTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOREGULATION; INFECTION; INFECTIOUS DIARRHEA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MEDICAL LITERATURE; NONHUMAN; REVIEW; SACCHAROMYCES BOULARDII; STREPTOCOCCUS THERMOPHILUS; TRAVELLER DIARRHEA;

EID: 33645295508     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-006-0005-9     Document Type: Review

References (56)

1. Van Loo JA: Prebiotics promote good health: The basis, the potential, and the emerging evidence. J Clin Gastroenterol 2004, 38(Suppl 2):S70-S75.
2. Backhed F, Ley RE, Sonnenburg JL, et al.: Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
3. Pickard KM, Bremner AR, Gordon JN, et al.: Microbial-gut interactions in health and disease. Immune responses. Best Pract Res Clin Gastroenterol 2004, 18:271-285.
4. Isolauri E, Salminen S: Probiotics, gut inflammation, and barrier function. Gastroenterol Clin N Am 2005, 34:437-450.
5. MacDonald TT, Gordon JN: Bacterial regulation of intestinal immune responses. Gastroenterol Clin N Am 2005, 34:401-412.
6. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126:1620-1633.
7. Philpott DJ, Giradin SE: The role of toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 2004, 41: 1099-1108.
8. Madsen K, Cornish A, Soper P, et al.: Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121:580-591.
9. Watson JL, McKay DM: The immunophysiological impact of bacterial cpGDNA on the gut. Clin Chim Acta 2005, In press.
10. Szajewska H, Kotowska M, Mrukowicz JZ, et al.: Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001, 138:361-365.
11. Thibault H, Aubert-Jacquin C, Goulet O: Effects of long-term consumption of fermented infant formula with Bifidobacterim breve and Streptococcus thermophilus on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 2004, 39:147-152.
12. Choraqui JP, VanEgroo LD, Fichot MC: Acidified milk formula supplemented with Bifidobacterium lactis: Impact on diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 2004, 38:288-292.
13. Weizman Z, Asli G, Alsheikh A: Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Pediatrics 2005, 115:5-9.
14. Pereg D, Kimhi O, Tirosh A, et al.: The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population. Am J Infect Control 2005, 33:122-125.
15. Allen SJ, Okoko B, Martinez E, et al.: Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2004, 2:CD003048.
16. Huang JS, Bousvaros A, Lee JW, et al.: Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002, 47:2625-2634.
17. Szajewska H, Mrukowicz JZ: Probiotics in the treatment and prevention of acute infectious diarrhea in infants: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001, 33(Suppl 2):S17-S25.
18. VanNiel CW, Feudtner C, Garrison MM, et al.: Lactobacillus therapy for acute infectious diarrhoea in children: a meta-analysis. Pediatrics 2002, 109:678-684.
19. Kurugol Z, Koturoglu G: Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Pediatr 2005, 94:44-47.
20. Salazar-Lindo E, Miranda-Langschwanger P, Chea-Woo MC, et al.: Lactobacillus casei strain GG in the treatment of infants with watery diarrhea: A randomized, double-blind, placebo-controlled clinical trial (ISRCTN67363048). BMC Pediatr 2004, 4:18.
21. Costa-Ribeiro H, Ribeiro TC, Mattos AP, et al.: Limitations of probiotic therapy in acute sever dehydrating diarrhea. J Pediatr Gastroenterol Nutr 2003, 36:112-115.
22. Resta-Lenert S, Barrett KE: Live probiotics protect intestinal epithelial cells from infection with enteroinvasive Escherichia coli (EIEC). Gut 2005, 52:988-997.
23. Paton AW, Jennings MP, Morona R, et al.: Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology 2005, 128:1219-1228.
24. Marteau PR, Vrese Md, Cellier CJ, et al.: Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001, 73 (Suppl):430s-436s.
25. Surawicz CM: Probiotics, antibiotic-associated diarrhea, and Clostridium difficile in humans. Best Pract Res Clin Gastroenterol 2003, 17:775-783.
26. Erdeve O, Tiras U, Dallar Y: The probiotic effect of Saccharomyces boulardii in a pediatric age group. J Trop Pediatrics 2004, 50:234-235.
27. Kotowska M, Albrecht P, Szajewska H: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005, 21:583-590.
28. Arvola T, Laiho K, Torkkeli S, et al.: Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatrics 1999, 104:e64, Available at http://www. pediatrics.org/cgi/content/full/104/5/e64.
29. Vanderhoof JA, Whitney DB, Antonson DL, et al.: Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999, 135:564-568.
30. Cremonini F, Caro SD, Nista EC, et al.: Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhea. Aliment Pharmacol Ther 2002, 16:1461-1467.
31. D'Souza AL, Rajkumar C, Cooke J, et al.: Probiotics in the prevention of antibiotic associated diarrhea: a meta-analysis. BMJ 2002, 324:1361-1366.
32. Szajewska H, Mrukowicz J: Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic associated diarrhea. Aliment Pharmacol Ther 2005, 22:365-372.
33. Pepin J, Valiquette L, Alary ME, et al.: Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004, 171:466-472.
34. Muto CA, Pokrywka M, Shutt K, et a!.: A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005, 26:273-280.
35. Surawicz CM, McFarland LV, Greenberg RN, et al.: The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000, 31:1012-1017.
36. Plummer S, Weaver MA, Harris JC, et a!.: Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhea. Int Microbiol 2004, 7:59-62.
37. Dendukuri N, Costa V, McGregor M, et al.: Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea. CMAJ 2005, 173:167-170.
38. Kamiji MM, Oliveira RB: Non-antibiotic therapies for Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2005, 17:973-981.
39. Linsalata M, Russo F, Berloco P, et al.: The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylon-infected gastric mucosa. Helicobacter 2004, 9:165-172.
40. Sheu BS, WuJJ, Lo CY, et al.: Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylon eradication. Aliment Pharmacol Ther 2002, 16:1669-1675.
41. Sykora J, Valeckova K, Amlerova J, et al.: Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 on the eradication of H. pylori in children. J Clin Gastroenterol 2005, 39:692-698.
42. Nista EC, Candelli M, Cremonini F, et al.: Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004, 20:1181-1188.
43. Cremonini F, Caro SD, Covino M, et at.: Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects : A parallel group, triple-blind, placebo-controlled study. Am J Gastroenterol 2002, 97:2744-2749.
44. Armuzzi A, Cremonini F, Bartolozzi F, et al.: Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001, 63:1-7.
45. Myllyuoma E, Veijola L, Ahlroos T, et al.: Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled double-blind randomized pilto study. Aliment Pharmacol Ther 2005, 21:1263-1272.
46. Fric P, Zavoral M: The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 2003, 15:313-315.
47. Tursi A, Brandimarte G, Giorgetti GM, et al.: Beclamethasone diproprionate plus VSL#3 for the treatment of mild to moderate diverticular colitis: An open, pilot study. J Clin Gastroenterol 2005, 39:644-645.
48. Salminen MK, Tynkkynen S, Rautelin H, et al.: The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, non-infectious diarrhea in HIV patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study. HIV Clin Trials 2004, 5:183-191.
49. Cunningham-Rundles S, Ahrne S, Bengmark S, et al.: Probiotics and immune response. Am J Gastroenterol 2000, 95(Suppl 1):S22-S25.
50. Heiser CR, Ernst JA, Barrett JT, et al.: Probiotics, soluble fiber, and L-glutamine (GLN) reduce nelfinavir (NFV)-or lopinavir/ritonavir (LPV/r)-related diarrhea. Int Assoc Physicians AIDS Care (Chic III) 2004, 3:121-129.
51. Hopkins MJ, Macfarlane GT: Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Environ Microbiol 2003, 69: 1920-1927.
52. Langlands SJ, Hopkins MJ, Coleman N, et al.: Prebiotic carbohydrates modify mucosa associated microflora of the human large bowel. Gut 2004, 53:1610-1616.
53. Lewis S, Burmeister S, Cohen S, et al.: Failure of dietary oligofructose to prevent antibiotic-associated diarrhea. Aliment Pharmacol Ther 2005, 21:469-477.
54. Lewis S, Burmeister S, Brazier J: Effect of prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol 2005, 3:442-448.
55. Rayes N, Seehofer D, Hansen S, et al.: Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation 2002, 74:123-128.
56. Anderson ADC, McNaught CE, Jain PK, et al.: Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004, 53:241-245.